MITO

Stealth BioTherapeutics Corp. ADS
MITO

Overview Fund Activity
Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

7 hedge funds and large institutions have $3.91M invested in Stealth BioTherapeutics Corp. ADS in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
KCM
Kingdon Capital Management
New York
$2.28M
2
Millennium Management
Millennium Management
New York
$666K
3
DIM
DC Investments Management
Virginia
$646K
4
Bank of America
Bank of America
North Carolina
$310K
5
CCA
Catalyst Capital Advisors
New York
$7K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
KCM
1
Kingdon Capital Management
New York
$2.28M +$2.28M +178,453 New
Millennium Management
2
Millennium Management
New York
$666K +$666K +51,928 New
DIM
3
DC Investments Management
Virginia
$646K +$646K +50,420 New
Bank of America
4
Bank of America
North Carolina
$310K +$310K +24,190 New
CCA
5
Catalyst Capital Advisors
New York
$7K +$7K +568 New
UBS Group
6
UBS Group
Switzerland
$1K +$1K +65 New